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Abstract
Background
The cardiovascular consequences of obstructive sleep apnoea (OSA) differ by sex. We
hypothesized that sex influences the severity of acute coronary syndrome (ACS) in patients
with OSA. OSA was defined as an apnoea–hypopnoea index (AHI)>15 eventsh-1. We eval-
uated the severity of ACS according to the ejection fraction, Killip class, number of diseased
vessels, number of stents implanted and plasma peak troponin level.
Methods
We included 663 men (mean±SD, AHI 37±18 eventsh-1) and 133 women (AHI 35±18
eventsh-1) with OSA.
Results
The men were younger than the women (59±11 versus 66±11 years, p<0.0001), exhibited a
higher neck circumference (p<0.0001), and were more likely to be smokers and alcohol
users than women (p<0.0001, p = 0.0005, respectively). Body mass index and percentage
of hypertensive patients or diabetics were similar between sexes. We observed a slight
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tendency for a higher Killip classification in women, although it was not statistically signifi-
cant (p = 0.055). For men, we observed that the number of diseased vessels and the num-
ber of stents implanted were higher (p = 0.02, p = 0.001, respectively), and a decrease in
the ejection fraction (p = 0.002).
Conclusions
This study shows that sex in OSA influences the severity of ACS. Men show a lower ejection
fraction and an increased number of diseased vessels and number of stents implanted.
Introduction
Obstructive sleep apnoea (OSA) is a common disease that affects approximately 10% of the
middle-aged population and becomes more prevalent with age. It has been estimated that OSA
affects at least 17% of men and 9% of women [1,2]. Obstructive apnoeic events incorporate a
range of stressors that activate mechanisms contributing to the initiation and progression of
cardiac diseases [3]. According to published data, OSA has been associated with significant
cardiovascular morbidity and mortality and seems to be an independent risk factor for cardio-
vascular diseases [4,5]. Epidemiological studies suggest an association between OSA and hyper-
tension, coronary heart disease, heart failure, and stroke [4]. Moreover, OSA is associated with
an increased severity of acute coronary syndrome (ACS) [6]. Nevertheless, the cardiovascular
consequences of OSA differ by sex as epidemiological studies suggest sex-based differences in
the association between OSA and cardiovascular outcomes [7–9]. The effect of the gender into
OSA associated cardiovascular comorbidities remain incompletely understood because of the
underrepresentation of women in prior studies exploring the burden of comorbidities associ-
ated with OSA. A recent study which includes a large sample size of men and women with
OSA reported sex-differences on the prevalence of comorbidities associated with OSA, as
ischaemic heart disease were more prevalent in men with OSA [10]. Further clinical trials are
needed to assess the role of sex in the context of severity of cardiovascular comorbidities associ-
ated with OSA.
We hypothesized that sex-specific differences in the pathophysiology of OSA would result
in significant sex differences in the severity of ACS. Exploring the sex-specific aspects of OSA
and cardiovascular disease may have direct implications for risk stratification and management
of these patients.
Methods
Study Design and Subjects
This was an ancillary study of the ISAACC study, a multicentre, open-label, parallel, prospec-
tive, randomized controlled trial (NCT01335087) (Continuous Positive Airway Pressure
(CPAP) in Patients With Acute Coronary Syndrome and Obstructive Sleep Apnoea (ISAACC))
[11]. The ISAACC study assesses the impact of CPAP treatment on the incidence of new cardio-
vascular events in patients with ACS and OSA. Briefly, the ISAACC study include consecutive
patients with an ACS diagnosis evaluated in coronary care units or cardiology hospitalization
wards at fourteen participating hospitals in Spain (men and women aged18 years). During a
hospital stay, these patients are subjected to cardio-respiratory polygraphy. Patients with an
apnoea–hypopnoea index (AHI)>15 eventsh−1 are randomized to CPAP treatment or
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conservative treatment. Those patients with an AHI15 eventsh−1 are considered controls.
In this study, we investigate the effects of gender on the severity of ACS in patients with OSA
(Fig 1).
The exclusion criteria included previous treatment with CPAP; psychophysical inability to
complete questionnaires; the presence of any previously diagnosed sleep disorder; patients
with>50% central apnoeas or the presence of Cheyne–Stokes respiration; daytime sleepiness
(Epworth Sleepiness Scale (ESS)>10); patients with chronic diseases, e.g., neoplasms, renal
insufficiency (GFR<15 mLmin-11.73 m−2), severe chronic obstructive pulmonary disorder (a
forced expiratory volume in 1 s<50%), chronic depression, and other limiting chronic dis-
eases; a medical history that could interfere with the study objectives; any processes, whether
cardiovascular or otherwise, that reduce life expectancy to<1 year; and patients in cardiogenic
shock.
This study was approved by the ethics committee of each participating centre (approval
number in the coordinator centre: “Ethical Clinical Research Committee of Lleida (CEIC-L-
leida)”(2010–852)). All participants provided informed signed consent to participate in the
study. This study was conducted according to the principles expressed in the Declaration of
Helsinki.
Procedures
The ISAACC study procedures have been described previously [6,11]. All the included patients
underwent an attended respiratory polygraphy in the sleep laboratory of each centre, according
Fig 1. Study flowchart showing recruitment for the study.RP: respiratory polygraphy; ESS: Epworth Sleepiness Scale; CPAP: continuous positive
airway pressure; OSA: obstructive sleep apnoea.
doi:10.1371/journal.pone.0159207.g001
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to the guidelines of the Spanish national consensus on the apnoea-hypopnoea syndrome [12].
All the participating hospitals used the same model of polygraph (Embletta; ResMed, Bella
Vista, Australia). Respiratory polygraphy included continuous recording of oronasal flow and
pressure, heart rate, thoracic and abdominal respiratory movements, and oxygen saturation
(SaO2). Polygraphy data were scored manually by trained personnel. Apnoea was defined as
an interruption of oronasal airflow for more than 10 seconds. Hypopnoea was defined as a
decrease in arterial oxygen saturation>4%. Respiratory polygraphy studies were performed
without supplemental oxygen. The AHI was defined as the number of apnoeas plus hypopnoeas
per hour of recording, and the TSat90 was defined as the percentage of recording time with a
SaO2 less than 90%. The degree of daytime sleepiness (ESS score) was assessed in patients
treated in the coronary care unit with a diagnosis of ACS. During patient admission, an electro-
cardiogram evaluation and Killip classification were performed. To provide a clinical estimate of
the severity of the myocardial derangement, each patient was classified into one of the following
classes: I) no heart failure, with no clinical signs of cardiac decompensation; II) heart failure as
demonstrated by the presence of rales, an S3 gallop, and/or venous hypertension; III) severe
heart failure or frank pulmonary oedema; and IV) cardiogenic shock [13]. During the patient´s
hospital stay, we evaluated the severity of ACS according to the ejection fraction, the Killip scale,
number of affected vessels, number of stents implanted and peak troponin level.
Statistical analysis
Mean (and standard deviation) or absolute frequency (and percentage) was used to describe
quantitative and qualitative variables, respectively. First, a homogeneity analysis was performed
to compare men and women with regards to anthropometric, clinical, treatment variables and
ACS-related risk factors, using the Mann-Whitney test or Fisher test to assess the significance of
the differences. Second, the association of sex with ACS severity-related variables was assessed
using linear regression models and computing the corresponding p-values. Variables potentially
confounded with sex, as detected in the homogeneity analysis, were also considered in the models
to calculate an adjusted p-value (age, ESS, neck circumference, tobacco exposure (pack-years)
and alcohol). Finally, an analysis to evaluate the association of sex with ACS severity variables,
while taking into account the OSA severity (moderate OSA for AHI between 15–30 vs. severe
OSA for AHI30), was performed. For this purpose, stratified analyses for moderate and severe
OSA patients were performed, using the same models as previously described. Further homoge-
neity analyses to detect variables potentially confounded to sex were also applied by each OSA
severity level to determine the variables to be considered in the adjusted models. All analyses were
performed using the R statistical package, setting the threshold for significance at 5% (α = 0.05).
Sample size
The sample population included 133 women and 663 men, which provided a statistical power
of 80% to detect a minimum increase in mean troponin levels (scaled) of 16.25% and a mini-
mum decrease in the mean ejection fraction of 5.09% in men with respect to women. These
calculations were performed based on the mean values and standard deviations reported in
Table 1 and using a two-sample T-test to statistically assess the differences with a 5% type I
error (α = 0.05).
Results
A total of 663 men and 133 women with OSA were included. Anthropometric, clinical vari-
ables and ACS-related risk factors are presented in Table 2. The women were older than the
men (p<0.0001), and the men showed slightly, but significantly, higher ESS scores than the
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women (p = 0.03). Additionally, men exhibited a higher neck circumference (p<0.0001) and
were more likely than women to be smokers and alcohol users (p<0.0001, p = 0.0005, respec-
tively). Compared with men, women used more diuretics and antacids (p = 0.0006, p = 0.0008,
respectively).
In relation to ACS severity, the percentages of patients with Killip classes II-IV were higher
among women (p = 0.02). The analysis adjusted for age, ESS score, neck circumference,
tobacco exposure (pack-years) and alcohol revealed a slight tendency for a higher Killip classi-
fication in women, although this difference was not statistically significant (p = 0.055). Mean
troponin levels were similar between groups (p = 0.48) (Table 1). For the group of men, the
adjusted analysis showed that the number of diseased vessels and number of stents implanted
were higher (p = 0.02, p = 0.001, respectively), and the men also exhibited a decrease in the
ejection fraction (p = 0.002) (Table 1) (Fig 2).
To further evaluate the strength of the effect of the sex of OSA patients on ACS severity-
related variables, we classified the patients into two groups according to OSA severity; specifi-
cally, we analysed the differences in sex for ACS severity-related variables in patients with
severe (AHI30 eventsh-1) and moderate (AHI 15–30 eventsh-1) OSA. The results showed
that men with moderate OSA had a higher number of stents implanted (p = 0.02) than women
with moderate OSA. Moreover, the analysis adjusted by age, ESS score, neck circumference,
dyslipidemia, tobacco exposure and alcohol revealed that the mean ejection fraction was lower
in men with moderate OSA (p = 0.003). For severe OSA patients, the men exhibited a lower
Killip classification, a higher number of diseased vessels and a higher number of stents
Table 1. Differences in ACS severity-related variables betweenmen and womenwith OSA.
OSA patients (n = 796) Sex p-value Adjusted p-value
Women—(n = 133) Men—(n = 663)
ACS category * 0.34 0.8
Unstable 74 (11.56%) 17 (16.50%) 57 (10.61%)
Non-STEMI 306 (47.81%) 45 (43.69%) 261 (48.60%)
STEMI 260 (40.62%) 41 (39.81%) 219 (40.78%)
Killip classiﬁcation * 0.02 0.055
Killip I 544 (89.92%) 86 (84.31%) 458 (91.05%)
Killip II 52 (8.60%) 12 (11.76%) 40 (7.95%)
Killip III 6 (0.99%) 3 (2.94%) 3 (0.60%)
Killip IV 3 (0.50%) 1 (0.98%) 2 (0.40%)
Number of diseased vessels * 0.02 0.02
0 17 (2.41%) 5 (4.31%) 12 (2.04%)
1 333 (47.30%) 61 (52.59%) 272 (46.26%)
2 198 (28.12%) 33 (28.45%) 165 (28.06%)
3 156 (22.16%) 17 (14.66%) 139 (23.64%)
Number of stents implanted 1.47 (0.99) 1.19 (0.68) 1.53 (1.03) 0.001 0.001
Ejection fraction, % 55.02 (10.83) 57.38 (11.16) 54.54 (10.71) 0.02 0.002
Peak troponin, rank+ 0.50 (0.29) 0.48 (0.30) 0.51 (0.29) 0.48 0.11
CPK, U/l 744.45 (1133.58) 582.24 (879.00) 776.70 (1175.71) 0.12 0.17
Data are presented as the mean (and standard deviation) and frequency (and percentage) for quantitative and qualitative variables, respectively. P-values
and adjusted p-values to assess the differences were computed with linear regression models, considering age, ESS, neck circumference, tobacco
exposure (pack-years) and alcohol for adjustment.
* Numerical order for the categories was considered in the linear regression models.
+ For assessing differences in the peak troponin levels, the rank of the data was used for each type of troponin evaluated.
doi:10.1371/journal.pone.0159207.t001
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implanted (p = 0.001, p = 0.02 and p = 0.01, respectively). Nevertheless, after adjustment, only
the number of stents implanted was statistically significant (p = 0.02) (Table 3) (Fig 3).
Discussion
The results of this observational study suggest that in patients with OSA, sex influences the
severity of ACS. Men with OSA showed a higher ACS severity than women, as well as a
Table 2. Differences in anthropometric, clinical, and treatment variables and ACS-related risk factors betweenmen and women with OSA.
OSA patients (n = 796) Sex p-value
Women (n = 133) Men (n = 663)
Age, years 60.46 (10.49) 65.56 (10.51) 59.44 (10.19) <0.00001
Apnoea-hypopnoea index eventsh-1 36.48 (18.09) 35.04 (17.70) 36.77 (18.17) 0.27
Oxigen desaturation endex >4% h-1 34.22 (37.23) 30.98 (37.79) 34.90 (37.11) 0.1
Minimum SaO2, % 80.87 (10.10) 81.25 (10.21) 80.79 (10.08) 0.76
Mean SaO2, % 90.74 (12.60) 91.11 (11.60) 90.66 (12.80) 0.8
Time with SaO2 <90%, min 51.48 (82.09) 57.56 (88.91) 50.24 (80.64) 0.98
Time with SaO2 <90%, % 14.09 (39.44) 14.23 (20.36) 14.06 (42.26) 0.76
Epworth Sleepiness Scale 5.46 (2.49) 4.99 (2.59) 5.55 (2.46) 0.03
Hypertensive patients 406 (53.99%) 76 (60.32%) 330 (52.72%) 0.14
Body mass index, kgm-2 29.36 (4.91) 29.82 (5.45) 29.27 (4.80) 0.67
Neck circumference, cm 41.17 (3.53) 37.59 (3.04) 41.86 (3.18) <0.00001
Diabetes mellitus 184 (24.50%) 34 (26.98%) 150 (24.00%) 0.5
Dyslipidaemia 392 (52.06%) 73 (57.94%) 319 (50.88%) 0.17
First episode of ACS 569 (82.11%) 91 (81.98%) 478 (82.13%) 1
Cardiomyopathy 163 (21.97%) 28 (22.76%) 135 (21.81%) 0.81
Stroke 25 (3.39%) 1 (0.82%) 24 (3.90%) 0.1
Current or former smoker 543 (72.40%) 59 (47.58%) 484 (77.32%) <0.00001
Smoker 0.0005
No 207 (27.60%) 65 (52.42%) 142 (22.68%)
Yes 348 (46.40%) 42 (33.87%) 306 (48.88%)
Former smoker 195 (26.00%) 17 (13.71%) 178 (28.43%)
Total tobacco exposure, pack-years 23.19 (27.30) 13.64 (21.21) 25.32 (28.05) <0.00001
Alcohol 0.0005
No 521 (72.66%) 116 (95.87%) 405 (67.95%)
Yes 190 (26.50%) 5 (4.13%) 185 (31.04%)
Former alcoholism 6 (0.84%) 0 (0%) 6 (1.01%)
Diuretics 141 (19.13%) 38 (31.15%) 103 (16.75%) 0.0006
Anticoagulants 51 (6.93%) 11 (9.02%) 40 (6.51%) 0.33
Antacids 202 (27.48%) 49 (40.16%) 153 (24.96%) 0.0008
Hypolipidemics 274 (37.18%) 52 (42.62%) 222 (36.10%) 0.18
β-Blockers 160 (21.71%) 30 (24.59%) 130 (21.14%) 0.4
Calcium antagonists 108 (14.69%) 22 (18.03%) 86 (14.03%) 0.26
Antiplatelet 165 (22.45%) 30 (24.59%) 135 (22.02%) 0.55
Insulin 48 (6.53%) 13 (10.66%) 35 (5.71%) 0.07
Oral antidiabetics 140 (19.02%) 26 (21.31%) 114 (18.57%) 0.53
Data are presented as the mean (and standard deviation) and absolute frequency (and percentage) for quantitative and qualitative variables, respectively.
SaO2: arterial oxygen saturation. P-values to assess differences in means or proportions between groups were computed using Mann-Whitney and Fisher
tests, respectively.
doi:10.1371/journal.pone.0159207.t002
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decrease in the ejection fraction, and an increase in the number of diseased vessels and the
number of stents implanted. To further investigate the strength of the association of ACS sever-
ity-related variables with OSA severity, we classified male and female patients according to
OSA severity. These results showed that with increasing severity of OSA, the gender-related
differences in the severity of ACS were more evident as men with severe OSA were also those
with a higher severity of ACS, with a higher number of stents implanted and a greater tendency
to have a higher number of affected vessels than women with severe OSA. Cigarettes and alco-
hol are well known risk factors for OSA and cardiovascular disease. The fact that men were sig-
nificantly more exposed to both of these risk factors could explain the differences in severity.
Nevertheless, the results previously indicated were adequately adjusted for this potentially con-
founding variables.
Despite several confounding factors, including age, sex and obesity, there is accumulating
evidence regarding strong associations between OSA and cardiovascular diseases, such as
hypertension [14,15], coronary artery disease (CAD) [16] and cerebrovascular disease [17–19].
Although the coexistence of these conditions with OSA not prove causality, epidemiological
data support the concept that OSA can participate in the initiation or progression of several
cardiovascular diseases [20–26]. Previous studies have suggested that sex influences the cardio-
vascular risk in OSA. However, the limited number of studies addressing the impact of sex on
the relationship between OSA and cardiovascular outcomes have yielded conflicting results.
The Sleep and Heart Health Study showed that men, but not women, with severe OSA showed
higher rates of total mortality [8] and cardiovascular events [7]. This study did not find any
association between OSA and mortality or other incident cardiovascular outcomes, including
stroke and coronary heart disease, in 3,000 women followed for over 8 years. However, severe
OSA accounted for only 3% of all the women sampled in the Sleep and Heart Health Study,
which might have biased the results. In contrast, a recent observational study in a cohort of
middle-aged (mean age 62.5±5.5 years) community-dwelling individuals comprising 752 men
Fig 2. Number of diseased vessels (A), number of stents (B) and ejection fraction (C) in men and womenwith OSA.
Percentages and means are represented by bars, and the standard deviation is represented by segments. P-values from
linear regression models to assess the significance of the association are shown. Adjusted p-values including total
tobacco exposure (pack-years), age, Epworth sleep score, neck circumference and alcohol are also shown. Integer values
were considered for models in (A).
doi:10.1371/journal.pone.0159207.g002
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and 893 women followed for 13 years showed that OSA was associated with incident heart fail-
ure or death only among women [9]. Together, this suggests that although women seem more
vulnerable to the cardiovascular consequences of OSA, the present study showed that men
show a greater severity of ACS.
The result of this study suggest that men showed an increased vascular involvement (higher
number of diseased vessels and number of stents implanted and lower ejection fraction). How-
ever, troponin levels related to ACS are similar between sex. A plausible explanation is that the
increased structural damage at myocardial level in men does not have to be accompanied by
greater myocardial damage when an acute ischemic episode occurs. Indeed, after and ACS the
Table 3. Differences in ACS severity-related variables betweenmen and womenwith moderate or severe OSA.
Moderate OSA (AHI 15–30) Severe OSA (AHI30)
OSA patients
(n = 377)
Sex p-
value
Adjusted p-
value (1)
OSA patients
(n = 446)
Sex p-
value
Adjusted p-
value (2)Women
(n = 72)
Men
(n = 305)
Women
(n = 67)
Men
(n = 379)
ACS category * 0.58 0.38 0.45 0.64
Unstable 37 (12.59%) 9 (15.52%) 28 (11.86%) 42 (11.29%) 9 (17.65%) 33 (10.28%)
Non-STEMI 136 (46.26%) 26
(44.83%)
110
(46.61%)
176 (47.31%) 21
(41.18%)
155
(48.29%)
STEMI 121 (41.16%) 23
(39.66%)
98 (41.53%) 154 (41.40%) 21
(41.18%)
133
(41.43%)
Killip classiﬁcation
*
0.82 0.33 0.001 0.16
Killip I 261 (91.9%) 49
(90.74%)
212
(92.17%)
300 (87.72%) 40
(75.47%)
260
(89.97%)
Killip II 22 (7.75%) 5 (9.26%) 17 (7.39%) 34 (9.94%) 9 (16.98%) 25 (8.65%)
Killip III 1 (0.35%) 0 (0%) 1 (0.43%) 5 (1.46%) 3 (5.66%) 2 (0.69%)
Killip IV 0 (0%) 0 (0%) 0 (0%) 3 (0.88%) 1 (1.89%) 2 (0.69%)
Number of
diseased vessels
*
0.61 0.43 0.02 0.052
0 7 (2.07%) 0 (0%) 7 (2.55%) 12 (3.08%) 5 (8.62%) 7 (2.11%)
1 165 (48.82%) 36
(56.25%)
129
(47.08%)
180 (46.27%) 28
(48.28%)
152
(45.92%)
2 98 (28.99%) 16
(25.00%)
82 (29.93%) 105 (26.99%) 18
(31.03%)
87 (26.28%)
3 68 (20.12%) 12
(18.75%)
56 (20.44%) 92 (23.65%) 7 (12.07%) 85 (25.68%)
Number of stents
implanted
1.48 (0.89) 1.25 (0.65) 1.54 (0.93) 0.02 0.08 1.48 (1.06) 1.14 (0.69) 1.54 (1.10) 0.01 0.02
Ejection fraction,
%
54.97 (10.76) 57.53
(10.39)
54.35
(10.78)
0.07 0.003 54.88 (10.86) 56.81
(12.12)
54.54
(10.61)
0.19 0.08
Peak troponin,
rank+
0.50 (0.29) 0.48 (0.28) 0.51 (0.29) 0.4 0.33 0.50 (0.29) 0.50 (0.32) 0.50 (0.28) 0.97 0.24
CPK, U/l 705.99
(1103.03)
573.05
(886.65)
739.23
(1,150.05)
0.31 0.85 764.01
(1,152.41)
551.33
(842.10)
798.61
(1,192.87)
0.17 0.08
Data are presented as the mean (and standard deviation) and absolute frequency (and percentage) for quantitative and qualitative variables, respectively. P-
values and adjusted p-values to assess the differences were computed with linear regression models, considering (1) age, ESS score, neck circumference,
dyslipidaemia, tobacco exposure (pack-years) and alcohol for adjustment in moderate OSA patients and (2) age, neck circumference, tobacco exposure
(pack-years), alcohol, diuretics, antacids and insulin for adjustment in severe OSA patients, respectively.
* Numerical order for the categories was considered in the linear regression models.
+ For assessing differences in the peak troponin levels, the rank of the data was used for each type of troponin evaluated
doi:10.1371/journal.pone.0159207.t003
Effect of Patient Sex on ACS Severity in OSA
PLOSONE | DOI:10.1371/journal.pone.0159207 July 14, 2016 8 / 12
consequences could be similar between gender in part due to the ischemic preconditioning pre-
viously postulated [29]. The influence of sex on the severity of ACS in OSA that we observed in
the present study may reflect sex differences in the pathobiology of OSA. In fact, the activation
of several pathogenic factors proposed as intermediate mechanisms linking OSA with cardio-
vascular disease such us sympathetic activation [27] and endothelial dysfunction [27,28] varies
between men and women. Moreover, OSA severity is more strongly positively associated with
higher plasma levels of biomarkers of subclinical myocardial injury such us high-sensitivity
troponin T in women compared with men [9]. The cardiac adaptations to haemodynamic
stress could also differ by sex, and these differences could explain why women with OSA
are better adapted to cardiac stress than men; this would also support the development of
Fig 3. Number of diseased vessels (A), number of stents (B) and ejection fraction (C) in men and women with
moderate or severe OSA. Percentages and means are represented by bars, and the standard deviation is represented
by segments. P-values from linear regression models to assess the significance of the association are shown. Adjusted p-
values including total tobacco exposure (pack-years), age, Epworth sleep score, neck circumference and alcohol are also
shown. Integer values were considered for models in (A).
doi:10.1371/journal.pone.0159207.g003
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ischaemic preconditioning in women that has been postulated in OSA [29]. Therefore, the sex
differences in the pathobiology of OSA may reflect differences in the response to cardiovascular
stressors and/or differences in the influence of OSA on cardiac injury or other cardiovascular
diseases.
The strength of our study was its multicentre design that comprised a large number of
patients. All participating centres performed the same methodology, and the sleep study was
performed with the same polygraph model. Nevertheless, our findings must be interpreted in
light of the limitations of the present study. First, we excluded patients with daytime sleepiness
that could be related to the most severe forms of OSA. However, the number of excluded
patients for these causes was relatively low (8%). Second, the diagnosis of OSA was based on
respiratory polygraphy, which could underestimate the severity of OSA. However, due to the
critical situation of the patients, full polysomnography monitoring could be a stressful proce-
dure for this high-risk patient group. Moreover, numerous studies have demonstrated the util-
ity of respiratory polygraphy for OSA diagnosis with similar results to polysomnography.
Third, this study comprises a limited number of women. However, this study is a large series of
patients consecutively included that reflect the incidence of this disease, and moreover, sample
size allows us to meet the objectives raised with an adequate statistical power. Despite these
limitations, our study provides evidence that sex in OSA influences the severity of ACS.
Conclusions
The results of the present study show that in OSA patients, patient sex influences the severity
of ACS, such that men showed an increase in the number of diseased vessels and number of
stents implanted and a lower ejection fraction with respect to women. The results of this study
indicate that personalized clinical attention in patients with OSA and ACS should be ade-
quately adapted based on sex. Further research assessing the survival of male and female OSA
patients with ACS in population-based studies is required before conclusions can be made
regarding patient survival.
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